Germany
Japan
United Kingdom
China
Products
View as table Download
Mouse Anti-Human CD40 Purified (100 ug)
| Reactivities | Human |
| Conjugation | Unconjugated |
Hamster Anti-Mouse/Rat CD40 Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse, Rat |
| Conjugation | Unconjugated |
CD40 mouse monoclonal antibody, clone B-B20, Biotin
| Applications | FC |
| Reactivities | Human |
| Conjugation | Biotin |
CD40 mouse monoclonal antibody, clone B-B20, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD40 mouse monoclonal antibody, clone B-B20, Purified
| Applications | FC |
| Reactivities | Human |
CD40 mouse monoclonal antibody, clone B-B20, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
Carrier-free (BSA/glycerol-free) CD40 mouse monoclonal antibody, clone OTI7H2 (formerly 7H2)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) CD40 mouse monoclonal antibody, clone OTI8C5 (formerly 8C5)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) CD40 mouse monoclonal antibody, clone OTI6C12 (formerly 6C12)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) CD40 mouse monoclonal antibody, clone OTI7F6 (formerly 7F6)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone G28.5)
| Applications | FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone G28.5)
| Applications | FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD79a (Clone ZL7-4)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD79a (Clone ZL7-4)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD40 (Clone A54 scFv)
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human, Monkey, Cynomolgus |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human, Monkey, Cynomolgus |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD40 (Clone 3/23)
| Applications | FC, IHC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD40 (Clone 3/23)
| Applications | FC, IHC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone FGK45)
| Applications | FC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD40 (Clone FGK45)
| Applications | FC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
CD40 mouse monoclonal antibody, clone OTI8B8 (formerly 8B8)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
CD40 mouse monoclonal antibody, clone OTI7H2 (formerly 7H2)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
CD40 mouse monoclonal antibody, clone OTI7H2 (formerly 7H2), Biotinylated
| Applications | WB |
| Reactivities | Human |
| Conjugation | Biotin |
CD40 mouse monoclonal antibody, clone OTI7H2 (formerly 7H2), HRP conjugated
| Applications | WB |
| Reactivities | Human |
| Conjugation | HRP |
CD40 mouse monoclonal antibody, clone OTI7H2 (formerly 7H2)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CD40 mouse monoclonal antibody, clone OTI8G5 (formerly 8G5)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
Active filters
Target Symbol
- CD40
Clonalities
- Monoclonal
Filter by
Category
Reactivities
Antibody Hosts
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (1)